These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 20024841

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Fragment-Based Drug Discovery--CHI's Fourth Annual Meeting. 6-7 April 2009, San Diego, CA, USA.
    Seneci P.
    IDrugs; 2009 Jun; 12(6):353-7. PubMed ID: 19517314
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Mitochondrial ion channels].
    Skalska J, Debska-Vielhaber G, Głab M, Kulawiak B, Malińska D, Koszela-Piotrowska I, Bednarczyk P, Dołowy K, Szewczyk A.
    Postepy Biochem; 2006 Jun; 52(2):137-44. PubMed ID: 17078503
    [Abstract] [Full Text] [Related]

  • 29. [Potassium channels and the development of new drugs].
    Kazić T, Gojković-Bukarica L.
    Med Pregl; 1998 Jun; 51(11-12):481-8. PubMed ID: 10081267
    [Abstract] [Full Text] [Related]

  • 30. Bright future of optical assays for ion channel drug discovery.
    Molokanova E, Savchenko A.
    Drug Discov Today; 2008 Jan; 13(1-2):14-22. PubMed ID: 18190859
    [Abstract] [Full Text] [Related]

  • 31. Assay technologies for screening ion channel targets.
    Mattheakis LC, Savchenko A.
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):124-34. PubMed ID: 11727318
    [Abstract] [Full Text] [Related]

  • 32. Epilepsy and ionic channels.
    Roll P, Szepetowski P.
    Epileptic Disord; 2002 Sep; 4(3):165-72. PubMed ID: 12446218
    [Abstract] [Full Text] [Related]

  • 33. The skeletal muscle channelopathies: distinct entities and overlapping syndromes.
    Davies NP, Hanna MG.
    Curr Opin Neurol; 2003 Oct; 16(5):559-68. PubMed ID: 14501839
    [Abstract] [Full Text] [Related]

  • 34. The Immunotherapeutics and Vaccine Summit - CHI's fifth annual meeting - novel vaccines: adjuvants and delivery systems: part 2.
    Jones SD.
    IDrugs; 2010 Oct; 13(10):692-4. PubMed ID: 20878589
    [Abstract] [Full Text] [Related]

  • 35. TRPA1 modulators in preclinical development.
    Viana F, Ferrer-Montiel A.
    Expert Opin Ther Pat; 2009 Dec; 19(12):1787-99. PubMed ID: 19939193
    [Abstract] [Full Text] [Related]

  • 36. The role of natural products in drug discovery and development in the new millennium.
    Harvey A.
    IDrugs; 2010 Feb; 13(2):70-2. PubMed ID: 20127553
    [Abstract] [Full Text] [Related]

  • 37. Receptor and voltage-operated ion channels in the central nervous system.
    Antkiewicz-Michaluk L.
    Pol J Pharmacol; 1995 Feb; 47(3):253-64. PubMed ID: 8714758
    [Abstract] [Full Text] [Related]

  • 38. [Channels: a new way to revisit pathology].
    Fournier E.
    Bull Acad Natl Med; 2014 Feb; 198(2):225-41; discussion 241-2. PubMed ID: 26263701
    [Abstract] [Full Text] [Related]

  • 39. Ion channels-related diseases.
    Dworakowska B, Dołowy K.
    Acta Biochim Pol; 2000 Feb; 47(3):685-703. PubMed ID: 11310970
    [Abstract] [Full Text] [Related]

  • 40. HTS techniques to investigate the potential effects of compounds on cardiac ion channels at early-stages of drug discovery.
    Netzer R, Bischoff U, Ebneth A.
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):462-9. PubMed ID: 12951809
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.